Simple and Effective Treatment for Otorhinolaryngologic Bleed

Abstract

Objective: To evaluate the effect of the Surgicel (absorbable hemostat, oxidized regenerated cellulose) in the treatment of otorhinolaryngologic bleed. Methods: A case-controlled study, for two types of treatment of acute otorhinologhic bleed. The study was conducted in the department of Otorhinolaryngology, Mosul General Hospital and alrhma Hospital, from May 2012 to May 2014. Out of 175 patients with acute otorhinolaryngologic bleed, 55 of them were treated with application of Surgicel to the site of bleed in throat, nose or ear in the ward, clinic, during operation or post-operative (Group I) and the other 120 were managed by conventional way (cautery, packs and/or ligation) (Group II). Results: Fifty-two patients, out of the 55 (94.5%) were treated with the application of Surgicel (Group I) and responded well to this way of management and the bleed stopped at once with no need for further treatment, while only in three patients with epistaxis treated by Surgicel application bleed recurred, so two of them were treated by electrical cautery and the third one by the application of Surgicel again. It has been seen that a statistically significantly higher cure rate in the patient treated by the application of Surgicel to bleed site, as compared with the patients treated by the conventional way (94.5% versus 77.5% with the P-value < 0.0001). Conclusions: The treatment of otorhinolaryngologic bleeding by Surgicel is simple, safe, effective method and worth to be tried.